Tuesday, January 31, 2017

Nature Reviews Immunology Contents February 2017 Volume 17 Number 2 pp 77-143

If you are unable to see the message below, click here to view.

Nature Reviews Immunology


Advertisement
Nature Reviews Cancer Focus on Tumour Metabolism

This Focus explores the dynamic and varied metabolism in tumour cells, discussing the importance of these pathways for many tumorigenic processes, such as tumour progression, survival, growth, epigenetic changes and how these can be translated to the clinic. 

Access the Focus free online.

Produced with support from Agios Pharmaceuticals, Inc.
 
 
TABLE OF CONTENTS
 
February 2017 Volume 17 Number 2
Nature Reviews Immunology cover
2015 2-year Impact Factor 39.416 Journal Metrics 2-year Median 31
In this issue
Research Highlights
Reviews
Correspondence

Also this month
Article series:
Cell death and immunity
 Featured article:
Disease tolerance and immunity in host protection against infection
Miguel P. Soares, Luis Teixeira & Luis F. Moita
Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 
RESEARCH HIGHLIGHTSTop

Inflammation: Inflammasome-related ageing
p77 | doi:10.1038/nri.2017.3
Increased expression of inflammasome-related gene modules in older individuals correlates with nucleotide metabolism dysfunction, IL-1β production and cardiovascular disease.

PDF


Immunometabolism: Complex metabolic responses to microbial stimuli
p78 | doi:10.1038/nri.2016.148
Different microbial stimuli lead to specific metabolic programmes in activated human monocytes.

PDF


Antibody responses: A thymic niche for plasma cells
p78 | doi:10.1038/nri.2017.2
Plasma cells accumulate in the ageing thymus and may provide protection against viral infections.

PDF


Tumour immunology: NLRC3 inhibits mTOR in colorectal cancer
p79 | doi:10.1038/nri.2016.152
NLRC3 protects against colorectal cancer by suppressing the proliferation of intestinal epithelial cells through inhibition of the PI3K-AKT-mTOR pathway.

PDF


Allergy: Neonatal IL-33 drives allergy
p80 | doi:10.1038/nri.2016.149
Interleukin-33 is a key driver of type 2 immunity in the developing neonatal lung of mice both in the steady state and in response to allergen exposure.

PDF


Autoimmune diseases: Inhibitor of adaptor protein shows self-antigen selectivity
p80 | doi:10.1038/nri.2017.5
A T cell receptor signalling inhibitor shows efficacy in autoimmune diseases without affecting immune responses to pathogens.

PDF


T cells: Something to chew on
p81 | doi:10.1038/nri.2017.4
Chewing induces the accumulation of T helper 17 cells in the mouth.

PDF


Nature Reviews Immunology
JOBS of the week
Director, Cancer Immunology Institute
Fox Chase Cancer Center (FCCC)
Assistant / Associate Professor of Immunology and Infectious Diseases
Harvard T. H. Chan School of Public Health
Postdoctoral Fellow in Immunology / Epigenetics / Infection Biology
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Immunology Scientist Positions
New York Blood Center
More Science jobs from
Nature Reviews Immunology
EVENT
18th International Congress of Mucosal Immunology (ICMI 2017)
19.07.17
Washington, D.C, USA
More science events from
 
REVIEWSTop
Disease tolerance and immunity in host protection against infection
Miguel P. Soares, Luis Teixeira & Luis F. Moita
p83 | doi:10.1038/nri.2016.136
Disease tolerance is a defence strategy that functions by improving tissue repair or by reducing the detrimental effect of inflammatory signals to prevent the harmful effects of pathogens. This Review describes the mechanisms underlying disease tolerance to infections and how these can be targeted therapeutically.
Abstract | Full Text | PDF
Article series: Cell death and immunity
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, Laurence Zitvogel & Guido Kroemer
p97 | doi:10.1038/nri.2016.107
Initiation of an adaptive immune response depends on the detection of both antigenic epitopes and adjuvant signals. Infectious pathogens and cancer cells often avoid immune detection by limiting the release of danger signals from dying cells. When is cell death immunogenic and what are the pathophysiological implications of this process?
Abstract | Full Text | PDF
Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures
Jan Felix & Savvas N. Savvides
p112 | doi:10.1038/nri.2016.134
Understanding how decoy receptors for cytokines and chemokines work requires in-depth insights into their structure. In this Review, the authors provide a structural overview of both mammalian and viral decoy receptors and highlight opportunities for leveraging their immunomodulatory activity for therapeutic purposes.
Abstract | Full Text | PDF | Supplementary information
RNA-binding proteins in immune regulation: a focus on CCCH zinc finger proteins
Mingui Fu & Perry J. Blackshear
p130 | doi:10.1038/nri.2016.129
In this Review, the authors summarize recent findings that illustrate the emerging roles of CCCH zinc finger proteins, which are involved in the regulation of multiple steps of RNA metabolism, in the regulation of immune responses including cytokine production, immune cell activation and immune homeostasis.
Abstract | Full Text | PDF | Supplementary information
 
CORRESPONDENCETop
The complement system is also important in immunogenic cell death
Junfei Jin & Songqing He
p143 | doi:10.1038/nri.2016.142
Full Text | PDF
Reply: The complement system is also important in immunogenic cell death
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, Laurence Zitvogel & Guido Kroemer
p143 | doi:10.1038/nri.2016.143
Full Text | PDF
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events


You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our feedback department

Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: